Breast Cancer Core Needle Biopsy Market Size, Trends, Analysis, and Outlook By Technology (MRI-Based Breast Biopsy, Ultrasound-Based Breast Biopsy, Mammography-Based (Stereotactic) Breast Biopsy, CT-Based Breast Biopsy, Others), By End-user (Biopharmaceut

Breast Cancer Core Needle Biopsy Market Size, Trends, Analysis, and Outlook By Technology (MRI-Based Breast Biopsy, Ultrasound-Based Breast Biopsy, Mammography-Based (Stereotactic) Breast Biopsy, CT-Based Breast Biopsy, Others), By End-user (Biopharmaceutical Companies Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology companies, Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030

The global Breast Cancer Core Needle Biopsy market size is poised to register 9.41% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Breast Cancer Core Needle Biopsy market across By Technology (MRI-Based Breast Biopsy, Ultrasound-Based Breast Biopsy, Mammography-Based (Stereotactic) Breast Biopsy, CT-Based Breast Biopsy, Others), By End-user (Biopharmaceutical Companies Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology companies, Academic & Research Institutes).

The breast cancer core needle biopsy market is experiencing rapid growth, influenced by various factors in 2024 and beyond. Core needle biopsy is a minimally invasive diagnostic procedure used to obtain tissue samples from breast abnormalities for pathological examination and cancer diagnosis. Market growth is driven by the increasing incidence of breast cancer, growing awareness about early detection and screening programs, and advancements in biopsy techniques and imaging technologies. Moreover, the shift towards personalized medicine and targeted therapies is driving the demand for accurate and reliable diagnostic procedures, fueling market expansion. Additionally, technological advancements in biopsy devices, such as vacuum-assisted systems and image-guided biopsy platforms, are enhancing procedural efficiency, diagnostic accuracy, and patient comfort, driving market adoption. Furthermore, strategic collaborations between medical device manufacturers, healthcare providers, and diagnostic laboratories are driving innovation, standardization, and market access efforts, shaping industry trends and competitiveness.

Breast Cancer Core Needle Biopsy Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Breast Cancer Core Needle Biopsy market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Breast Cancer Core Needle Biopsy survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Breast Cancer Core Needle Biopsy industry.

Key market trends defining the global Breast Cancer Core Needle Biopsy demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Breast Cancer Core Needle Biopsy Market Segmentation- Industry Share, Market Size, and Outlook to 2030

The Breast Cancer Core Needle Biopsy industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Breast Cancer Core Needle Biopsy companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Breast Cancer Core Needle Biopsy industry

Leading Breast Cancer Core Needle Biopsy companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Breast Cancer Core Needle Biopsy companies.

Breast Cancer Core Needle Biopsy Market Study- Strategic Analysis Review

The Breast Cancer Core Needle Biopsy market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-

• Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
• Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
• Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
• Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.

Breast Cancer Core Needle Biopsy Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Breast Cancer Core Needle Biopsy industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.

Breast Cancer Core Needle Biopsy Country Analysis and Revenue Outlook to 2030

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.

North America Breast Cancer Core Needle Biopsy Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Breast Cancer Core Needle Biopsy market segments. Similarly, Strong end-user demand is encouraging Canadian Breast Cancer Core Needle Biopsy companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Breast Cancer Core Needle Biopsy market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Breast Cancer Core Needle Biopsy Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Breast Cancer Core Needle Biopsy industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Breast Cancer Core Needle Biopsy market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Breast Cancer Core Needle Biopsy Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Breast Cancer Core Needle Biopsy in Asia Pacific. In particular, China, India, and South East Asian Breast Cancer Core Needle Biopsy markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.

Latin America Breast Cancer Core Needle Biopsy Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Breast Cancer Core Needle Biopsy Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Breast Cancer Core Needle Biopsy market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Breast Cancer Core Needle Biopsy.

Breast Cancer Core Needle Biopsy Market Company Profiles

The global Breast Cancer Core Needle Biopsy market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Intact Medical Corporation, Ethicon Surgical Technologies, Gallini SRL, Leica Biosystems Nussloch GmbH, Hologic, Inc., Argon Medical Devices, Encapsule Medical Devices LLC, Cook Medical Incorporated, Becton, Dickinson and Company, C.R. Bard, Inc.

Recent Breast Cancer Core Needle Biopsy Market Developments

The global Breast Cancer Core Needle Biopsy market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Breast Cancer Core Needle Biopsy Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis

• Pricing Analysis
• Value Chain Analysis
• SWOT Profile
• Market Dynamics- Trends, Drivers, Challenges
• Porter’s Five Forces Analysis
• Macroeconomic Impact Analysis
• Case Scenarios- Low, Base, High

Market Segmentation:

By Technology

MRI-Based Breast Biopsy

Ultrasound-Based Breast Biopsy

Mammography-Based (Stereotactic) Breast Biopsy

CT-Based Breast Biopsy

Others

By End-User

Biopharmaceutical Companies Hospitals & Diagnostic Laboratories

Pharmaceutical & Biotechnology companies

Academic & Research Institutes

Geographical Segmentation:

• North America (3 markets)
• Europe (6 markets)
• Asia Pacific (6 markets)
• Latin America (3 markets)
• Middle East Africa (5 markets)

Companies

Intact Medical Corporation

Ethicon Surgical Technologies

Gallini SRL

Leica Biosystems Nussloch GmbH

Hologic, Inc.

Argon Medical Devices

Encapsule Medical Devices LLC

Cook Medical Incorporated

Becton, Dickinson and Company

C.R. Bard, Inc.

Formats Available: Excel, PDF, and PPT